Kaleido Biosciences Inc. (KLDO)
NASDAQ · Healthcare
Kaleido Biosciences Inc. EPS 2016–2021
Kaleido Biosciences Inc. annual/quarterly eps history and growth rate from 2016 to 2021. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Kaleido Biosciences Inc. eps for the quarter ending September 30, 2021 was $0.54, a 16.92% decrease year-over-year.
- Kaleido Biosciences Inc. annual eps for 2020 was $2.44, a 27.38% decrease from 2019.
- Kaleido Biosciences Inc. annual eps for 2019 was $3.36, a 59.96% increase from 2018.
- Kaleido Biosciences Inc. annual eps for 2018 was $2.10, a 70.86% increase from 2017.
- Kaleido Biosciences Inc. annual eps for 2017 was $1.23.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Kaleido Biosciences Inc. EPS — FAQ
Kaleido Biosciences Inc. (KLDO) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KLDO's eps history?
The chart and table above show Kaleido Biosciences Inc.'s eps by year and by quarter, including the growth rate.